CapForce IBD Breakout Opportunities ETF (BOUT)
NYSEARCA: BOUT · Real-Time Price · USD
46.24
+0.01 (0.01%)
Jul 31, 2026, 4:00 PM EDT - Market closed
BOUT Holdings Information
BOUT is an equity ETF with a total of 28 individual holdings. The top holdings are Enliven Therapeutics stock at 7.15%, Travere Therapeutics at 7.01%, U.S. Bancorp at 6.90%, Bicara Therapeutics at 6.82%, and Waste Management at 6.65%.
Total Holdings
28
Top 10 Percentage
64.63%
Asset Class
Equity
ETF Category
Mid-Cap Growth
Assets
16.07M
PE Ratio
17.75
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | ELVN | Enliven Therapeutics, Inc. | 7.15% |
| 2 | TVTX | Travere Therapeutics, Inc. | 7.01% |
| 3 | USB | U.S. Bancorp | 6.90% |
| 4 | BCAX | Bicara Therapeutics Inc. | 6.82% |
| 5 | WM | Waste Management, Inc. | 6.65% |
| 6 | SWX: UBSG | UBS Group AG | 6.20% |
| 7 | TILE | Interface, Inc. | 6.17% |
| 8 | BAC | Bank of America Corporation | 5.98% |
| 9 | PNC | The PNC Financial Services Group, Inc. | 5.95% |
| 10 | GS | The Goldman Sachs Group, Inc. | 5.81% |
| 11 | VIK | Viking Holdings Ltd | 4.16% |
| 12 | RJF | Raymond James Financial, Inc. | 4.12% |
| 13 | LQDA | Liquidia Corporation | 4.03% |
| 14 | EHC | Encompass Health Corporation | 3.92% |
| 15 | TGTX | TG Therapeutics, Inc. | 3.83% |
| 16 | KNSA | Kiniksa Pharmaceuticals International, plc | 2.48% |
| 17 | FBK | FB Financial Corporation | 2.03% |
| 18 | HESM | Hess Midstream LP | 1.96% |
| 19 | LLY | Eli Lilly and Company | 1.95% |
| 20 | BNY | The Bank of New York Mellon Corporation | 1.94% |
| 21 | CHEF | The Chefs' Warehouse, Inc. | 1.17% |
| 22 | ENVA | Enova International, Inc. | 1.06% |
| 23 | IFS | Intercorp Financial Services Inc. | 0.95% |
| 24 | ASML | ASML Holding N.V. | 0.93% |
| 25 | CRS | Carpenter Technology Corporation | 0.83% |
As of Jul 30, 2026